Evidence map›Paper›PMID 32382777›Full record

ArticleSurgery today2020

Impact of a board certification system and implementation of clinical practice guidelines for pancreatic cancer on mortality of pancreaticoduodenectomy.

Masamichi Mizuma, Hiroyuki Yamamoto, Hiroaki Miyata, Mitsukazu Gotoh, Michiaki Unno, Tooru Shimosegawa, Yasushi Toh, Yoshihiro Kakeji, Yasuyuki Seto

Abstract read
In one paragraph

Article in Surgery today, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Masamichi MizumaJapan Pancreas Society, Osaka, Japan.
Hiroyuki YamamotoDepartment of Healthcare Quality Assessment, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Hiroaki MiyataDepartment of Healthcare Quality Assessment, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Mitsukazu GotohThe Japanese Society of Gastroenterological Surgery, Tokyo, Japan. mgotoh@fmu.ac.jp.
Michiaki UnnoJapan Pancreas Society, Osaka, Japan.
Tooru ShimosegawaJapan Pancreas Society, Osaka, Japan.
Yasushi TohThe Japanese Society of Gastroenterological Surgery, Tokyo, Japan.
Yoshihiro KakejiThe Japanese Society of Gastroenterological Surgery, Tokyo, Japan.
Yasuyuki SetoThe Japanese Society of Gastroenterological Surgery, Tokyo, Japan.

Funding

Japan Society for the Promotion of Science 16K10437Japan Society for the Promotion of Science 19K09111the Ministry of Health, Labour and Welfare of Japan 201221064A
6 · The paper itself

Abstract

purposesThe aim of this study was to clarify the impact of a board certification system and the implementation of clinical practice guidelines for pancreatic cancer (PC) on the mortality of pancreaticoduodenectomy in Japan.

methodsBy a web questionnaire survey via the National Clinical Database (NCD) for departments participating in the NCD, quality indicators (QIs) related to the treatment for PC, namely the board certification systems of various societies and the adherence to clinical practice guidelines for PC, were investigated between October 2014 and January 2015. A multivariable logistic regression analysis was performed to evaluate the relationship between the QIs and mortality of pancreaticoduodenectomy.

resultsOf 1415 departments that registered at least 1 pancreaticoduodenectomy between 2013 and 2014 in NCD, 631 departments (44.6%), which performed pancreaticoduodenectomy for a total of 11,684 cases, answered the questionnaire. The mortality of pancreaticoduodenectomy was positively affected by the board certification systems of the Japanese Society of Gastroenterological Surgery, Japanese Society of Hepato-Biliary-Pancreatic Surgery, Japanese Society of Gastroenterology, and Japanese Society of Medical Oncology as well as by institutions that used magnetic resonance imaging of ≥ 3 T for the diagnosis of PC in principle.

conclusionsThe measurement of the appropriate QIs is suggested to help improve the mortality in pancreaticoduodenectomy. Masamichi Mizuma and Hiroyuki Yamamoto equally contributed.

Indexed as

CertificationPractice Guidelines as TopicSpecialty BoardsGastroenterologyGeneral SurgeryHumansJapanMedical OncologyPancreatic NeoplasmsPancreaticoduodenectomyQuality Indicators, Health CareSocieties, MedicalSurveys and QuestionnairesBoard certificationClinical practice guidelinePancreatic cancerPancreaticoduodenectomyQuality indicator

Identifiers

PMID32382777
PMCPMC7501122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.